HP and Atrophy: As illustrated on Figure 5A, treatment with anti-IL-6 antibodies, in addition to mitigate muscle atrophy (Figure S4A), blunted the increase of three APR in the muscle (Hp, Serpina3n, Saa1), suggesting a potential link between their production and muscular atrophy.